Modulation of myeloid and T cells in vivo by Bruton's tyrosine kinase inhibitor ibrutinib in patients with metastatic pancreatic ductal adenocarcinoma

Modulation of myeloid and T cells in vivo by Bruton's tyrosine kinase inhibitor ibrutinib in patients with metastatic pancreatic ductal adenocarcinoma

Wnt/β-catenin signaling in cancers and targeted therapies

Biomedicines, Free Full-Text

Myeloid-derived suppressor cells in cancer - ScienceDirect

Cancers, Free Full-Text

Reprogramming the pancreatic cancer stroma and immune landscape by a silicasome nanocarrier delivering nintedanib, a protein tyrosine kinase inhibitor - ScienceDirect

B cells in pancreatic cancer stroma

Vaccines, Free Full-Text

Frontiers Natural Killer Cell Interactions With Myeloid Derived Suppressor Cells in the Tumor Microenvironment and Implications for Cancer Immunotherapy

T cells infiltrate PDA regardless of GM-CSF expression. A-C) IHC of

Beyond Bruton's tyrosine kinase inhibitors in mantle cell lymphoma: bispecific antibodies, antibody–drug conjugates, CAR T-cells, and novel agents, Journal of Hematology & Oncology

Therapeutic challenges and current immunomodulatory strategies in targeting the immunosuppressive pancreatic tumor microenvironment, Journal of Experimental & Clinical Cancer Research

Full article: Immunosuppressive tumor microenvironment modulation by chemotherapies and targeted therapies to enhance immunotherapy effectiveness

Frontiers Culprits of PDAC resistance to gemcitabine and immune checkpoint inhibitor: Tumour microenvironment components